Sanjaya Bandara Adikari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sanjaya Bandara Adikari has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Yu-Min Huang
Division of Neurology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
4 shared publications H. Link
Division of Neuroimmunology, Neurotec Department, Karolinska Institute
2 shared publicationsHans Link
2 shared publicationsA. Pettersson
Division of Neuroimmunology, NEUROTEC Department
1 shared publicationA. Sanna
Institute of Clinical Neurology, University of Sassari, Sassari, Italy
1 shared publicationAnn Kari Lefvert
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by Elsevier in Translational Research in Anatomy
- Vol. 44
Bilateral tensor vastus intermedius muscle identified during cadaveric dissection; an anatomical case report
- 24 June 2026
- Published by Elsevier in Translational Research in Anatomy
- Vol. 44
Open AccessBilateral tensor vastus intermedius muscle identified during cadaveric dissection; an anatomical case report
- Open Access
- 18 September 2014
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 8 (9) , e3179
Cutaneous Manifestations of Spotted Fever Rickettsial Infections in the Central Province of Sri Lanka: A Descriptive Study
Characteristic skin lesions play a key role in clinical diagnosis of spotted fever group rickettsioses and this study describes these cutaneous manifestations along with basic histological features. Study was conducted at Medical Unit, Teaching Hospital, Peradeniya, from November 2009 to October 2011, where a prospective data base of all rickettsial infections is maintained. Confirmation of diagnosis was made when IgM and IgG immunofluorescent antibody titre of 1/32 and >1/256 respectively. Of the 210 clinical cases, 134 had cutoff antibody titers for Rickettsia conorii antigen for confirmation. All these 134 patients had fever and skin rash, and of them 132(98%) had discrete maculopapular rash while eight (6%) had fern leaf type skin necrosis. Eight patients (6%) had healed tick bite marks. Average size of a skin lesion was 5 mm and rash involved 52% of body surface, distributed mainly in limbs and back of the chest. Generally the facial and leg skin was slightly oedematous particularly in old aged patients. Sixteen patients (12%) had pain and swelling of ankle joints where swelling extended to feet and leg. Biopsies from skin rash of six patients showed evidence of cutaneous vasculitis and of them, 247 bp region of the 17-kDa spotted fever group specific protein antigen was amplified using PCR. A discrete maculopapular rash and occasional variations such as fern leaf shape necrosis and arthritis are found in spotted fever group. Histology found vasculitis as the pathology of these lesions. Rickettsial organisms infect humans causing a wider array of clinical features and have re-emerged in Sri Lanka where three known disease entities; spotted fever group, murine typhus and scrub typhus do exist. These diseases cause clinical illnesses varying from mild febrile illness to severe multiple organ involvement even leading to fatal outcomes when there is a delay in diagnosis. Occasionally, clinical features could be nonspecific or atypical. Nevertheless, detection of skin lesions mostly facilitates the clinical diagnosis. Hence, clinicians need to be familiar with common as well as uncommon variations of skin manifestations. Being a treatable infection, early diagnosis is important and is heavily based on clinical features in settings where laboratory diagnostics are unavailable; at the same time delaying of treatment could lead to high morbidity and mortality. We identified some important variations of skin lesions associated with spotted fever group rickettsial infections which include fern leaf type skin necrosis mainly involving superficial skin with blackish discoloration which dries up with time and peels off. In addition, mild cutaneous oedema is seen over the face and ankles especially in older patients. Acute arthritis involving ankle joints were common manifestations which together with typical skin lesions facilitate the clinical diagnosis.
- 18 September 2014
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 8 (9) , e3179
Open AccessCutaneous Manifestations of Spotted Fever Rickettsial Infections in the Central Province of Sri Lanka: A Descriptive Study
Characteristic skin lesions play a key role in clinical diagnosis of spotted fever group rickettsioses and this study describes these cutaneous manifestations along with basic histological features. Study was conducted at Medical Unit, Teaching Hospital, Peradeniya, from November 2009 to October 2011, where a prospective data base of all rickettsial infections is maintained. Confirmation of diagnosis was made when IgM and IgG immunofluorescent antibody titre of 1/32 and >1/256 respectively. Of the 210 clinical cases, 134 had cutoff antibody titers for Rickettsia conorii antigen for confirmation. All these 134 patients had fever and skin rash, and of them 132(98%) had discrete maculopapular rash while eight (6%) had fern leaf type skin necrosis. Eight patients (6%) had healed tick bite marks. Average size of a skin lesion was 5 mm and rash involved 52% of body surface, distributed mainly in limbs and back of the chest. Generally the facial and leg skin was slightly oedematous particularly in old aged patients. Sixteen patients (12%) had pain and swelling of ankle joints where swelling extended to feet and leg. Biopsies from skin rash of six patients showed evidence of cutaneous vasculitis and of them, 247 bp region of the 17-kDa spotted fever group specific protein antigen was amplified using PCR. A discrete maculopapular rash and occasional variations such as fern leaf shape necrosis and arthritis are found in spotted fever group. Histology found vasculitis as the pathology of these lesions. Rickettsial organisms infect humans causing a wider array of clinical features and have re-emerged in Sri Lanka where three known disease entities; spotted fever group, murine typhus and scrub typhus do exist. These diseases cause clinical illnesses varying from mild febrile illness to severe multiple organ involvement even leading to fatal outcomes when there is a delay in diagnosis. Occasionally, clinical features could be nonspecific or atypical. Nevertheless, detection of skin lesions mostly facilitates the clinical diagnosis. Hence, clinicians need to be familiar with common as well as uncommon variations of skin manifestations. Being a treatable infection, early diagnosis is important and is heavily based on clinical features in settings where laboratory diagnostics are unavailable; at the same time delaying of treatment could lead to high morbidity and mortality. We identified some important variations of skin lesions associated with spotted fever group rickettsial infections which include fern leaf type skin necrosis mainly involving superficial skin with blackish discoloration which dries up with time and peels off. In addition, mild cutaneous oedema is seen over the face and ankles especially in older patients. Acute arthritis involving ankle joints were common manifestations which together with typical skin lesions facilitate the clinical diagnosis.
- Open Access
- 5 March 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (3) , e58122
Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication
Human herpesvirus 6A (HHV-6A) is a common virus with a worldwide distribution that has been associated with multiple sclerosis. Whether HHV-6A can replicate in dendritic cells (DC) and how the infection might modulate the functional properties of the cell are currently not well known and need further investigations. Here, we show that a non-productive infection of HHV-6A in DC leads to the up-regulation of HLA-ABC, via autocrine IFN-α signaling, as well as the up-regulation of HLA-DR and CD86. However, HHV-6A exposure reduces IL-8 secretion by DC and their capacity to stimulate allogenic T cell proliferation. The ability to suppress DC functions important for activation of innate and adaptive immune responses might be one successful strategy by which HHV-6A avoids the induction of appropriate host defense mechanisms, and thus facilitating persistent infection.
- 5 March 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (3) , e58122
Open AccessHuman Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication
Human herpesvirus 6A (HHV-6A) is a common virus with a worldwide distribution that has been associated with multiple sclerosis. Whether HHV-6A can replicate in dendritic cells (DC) and how the infection might modulate the functional properties of the cell are currently not well known and need further investigations. Here, we show that a non-productive infection of HHV-6A in DC leads to the up-regulation of HLA-ABC, via autocrine IFN-α signaling, as well as the up-regulation of HLA-DR and CD86. However, HHV-6A exposure reduces IL-8 secretion by DC and their capacity to stimulate allogenic T cell proliferation. The ability to suppress DC functions important for activation of innate and adaptive immune responses might be one successful strategy by which HHV-6A avoids the induction of appropriate host defense mechanisms, and thus facilitating persistent infection.
- 1 January 2005
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 158 (1-2) , 204-212
Multiple sclerosis: interferon-beta induces CD123+BDCA2− dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production
- 1 January 2005
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 158 (1-2) , 204-212
Multiple sclerosis: interferon-beta induces CD123+BDCA2− dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production
- 1 November 2004
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 156 (1-2) , 163-170
Dendritic cells activate autologous T cells and induce IL-4 and IL-10 production in myasthenia gravis
- 1 November 2004
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 156 (1-2) , 163-170
Dendritic cells activate autologous T cells and induce IL-4 and IL-10 production in myasthenia gravis
- Open Access
- 7 October 2004
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 138 (2) , 230-236
Interferon-γ-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis
This study was designed to investigate the therapeutic effects of interferon (IFN)‐γ‐modulated dendritic cells (DC) in experimental autoimmune myasthenia gravis (EAMG). We induced EAMG in Lewis rats by immunization with Torpedo nicotinic acetylcholine receptor (nAChR) and adjuvant. On day 33 post‐immunization (p.i.), splenic DC were prepared, exposed to IFN‐γ alone (IFN‐γ‐DC) or to IFN‐γ in combination with 1‐methyl‐DL‐tryptophan (1‐MT), the specific inhibitor of indoleamine 2,3‐dioxygenase (IDO) (IFN‐γ + 1‐MT‐DC), and injected subcutaneously into rats with incipient EAMG on day 5 p.i. A control group of EAMG rats received naive DC on day 5 p.i., while another group received 1‐MT every other day, intraperitoneally (p.i.), from days 5 to 41 p.i. The severity of clinical signs of EAMG was reduced dramatically in IFN‐γ‐DC‐treated rats compared to rats receiving naive DC, IFN‐γ + 1‐MT‐DC or 1‐MT alone. The number of plasma cells secreting nAChR antibodies was reduced and the expression of B cell activation factor (BAFF) on splenic and lymph node mononuclear cells (MNC) was down‐regulated in rats treated with IFN‐γ‐DC. In vitro co‐culture of MNC derived from EAMG rats with IFN‐γ‐DC produced relatively few cells secreting nAChR antibodies. Addition of 1‐MT to the co‐culture significantly increased the number of cells secreting nAChR antibodies. We conclude that IFN‐γ‐DC reduced the number of plasma cells secreting nAChR antibodies in an IDO‐dependent manner and ameliorated the development of EAMG in Lewis rats.
- 7 October 2004
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 138 (2) , 230-236
Open AccessInterferon-γ-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis
This study was designed to investigate the therapeutic effects of interferon (IFN)‐γ‐modulated dendritic cells (DC) in experimental autoimmune myasthenia gravis (EAMG). We induced EAMG in Lewis rats by immunization with Torpedo nicotinic acetylcholine receptor (nAChR) and adjuvant. On day 33 post‐immunization (p.i.), splenic DC were prepared, exposed to IFN‐γ alone (IFN‐γ‐DC) or to IFN‐γ in combination with 1‐methyl‐DL‐tryptophan (1‐MT), the specific inhibitor of indoleamine 2,3‐dioxygenase (IDO) (IFN‐γ + 1‐MT‐DC), and injected subcutaneously into rats with incipient EAMG on day 5 p.i. A control group of EAMG rats received naive DC on day 5 p.i., while another group received 1‐MT every other day, intraperitoneally (p.i.), from days 5 to 41 p.i. The severity of clinical signs of EAMG was reduced dramatically in IFN‐γ‐DC‐treated rats compared to rats receiving naive DC, IFN‐γ + 1‐MT‐DC or 1‐MT alone. The number of plasma cells secreting nAChR antibodies was reduced and the expression of B cell activation factor (BAFF) on splenic and lymph node mononuclear cells (MNC) was down‐regulated in rats treated with IFN‐γ‐DC. In vitro co‐culture of MNC derived from EAMG rats with IFN‐γ‐DC produced relatively few cells secreting nAChR antibodies. Addition of 1‐MT to the co‐culture significantly increased the number of cells secreting nAChR antibodies. We conclude that IFN‐γ‐DC reduced the number of plasma cells secreting nAChR antibodies in an IDO‐dependent manner and ameliorated the development of EAMG in Lewis rats.
- 1 July 2004
- Published by Elsevier in Neurobiology of Disease
- Vol. 16 (2) , 461-467
Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells
- 1 July 2004
- Published by Elsevier in Neurobiology of Disease
- Vol. 16 (2) , 461-467
Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells
- Open Access
- 1 April 2004
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 59 (6) , 600-606
Interleukin‐10‐Modulated Immature Dendritic Cells Control the Proinflammatory Environment in Multiple Sclerosis
Multiple sclerosis (MS) is a disabling, inflammatory, demyelinating disease of the central nervous system considered to be mediated by autoreactive T cells. Dendritic cells (DC), being professional antigen‐presenting cells, play a pivotal role in the decision between T‐cell activation and anergy. It has been suggested that mature DC (mDC) induce immunity, whereas immature DC (imDC) have the potential to induce tolerance. In this study, we investigated the effects of autologous imDC versus autologous mDC on lymphocytes with respect to the expression of functionally important cell‐surface molecules and production of cytokines. Our aims were to investigate whether the maturation status of DC differs between MS and healthy controls (HC) and to explore whether the effects of DC on T‐cell responses differ between MS and HC. DC were generated from adherent blood mononuclear cells from patients with MS and HC. imDC were obtained by culture with either granulocyte–macrophage colony‐stimulating factor (GM‐CSF) + interleukin‐4 (IL‐4) or GM‐CSF + IL‐4 + IL‐10. mDC were obtained by adding lipopolysaccharide to DC cultures. Upon coculture with autologous lymphocytes, mDC activated the autologous T cells as reflected by increased CD25 and cytotoxic T‐lymphocyte antigen‐4 expression on CD4+ T cells together with the increased production of both T helper 1 (Th1) (IL‐2 and interferon‐γ) and Th2 (IL‐10 and IL‐4) cytokines. Unmodulated naïve imDC induced the production of only IL‐4. An exposure of imDC to IL‐10 induced the production of IL‐4 as well as IL‐10 by autologous lymphocytes. We hypothesize that such imDC are important in controlling the proinflammatory environment in vivo in patients with MS.
- 1 April 2004
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 59 (6) , 600-606
Open AccessInterleukin‐10‐Modulated Immature Dendritic Cells Control the Proinflammatory Environment in Multiple Sclerosis
Multiple sclerosis (MS) is a disabling, inflammatory, demyelinating disease of the central nervous system considered to be mediated by autoreactive T cells. Dendritic cells (DC), being professional antigen‐presenting cells, play a pivotal role in the decision between T‐cell activation and anergy. It has been suggested that mature DC (mDC) induce immunity, whereas immature DC (imDC) have the potential to induce tolerance. In this study, we investigated the effects of autologous imDC versus autologous mDC on lymphocytes with respect to the expression of functionally important cell‐surface molecules and production of cytokines. Our aims were to investigate whether the maturation status of DC differs between MS and healthy controls (HC) and to explore whether the effects of DC on T‐cell responses differ between MS and HC. DC were generated from adherent blood mononuclear cells from patients with MS and HC. imDC were obtained by culture with either granulocyte–macrophage colony‐stimulating factor (GM‐CSF) + interleukin‐4 (IL‐4) or GM‐CSF + IL‐4 + IL‐10. mDC were obtained by adding lipopolysaccharide to DC cultures. Upon coculture with autologous lymphocytes, mDC activated the autologous T cells as reflected by increased CD25 and cytotoxic T‐lymphocyte antigen‐4 expression on CD4+ T cells together with the increased production of both T helper 1 (Th1) (IL‐2 and interferon‐γ) and Th2 (IL‐10 and IL‐4) cytokines. Unmodulated naïve imDC induced the production of only IL‐4. An exposure of imDC to IL‐10 induced the production of IL‐4 as well as IL‐10 by autologous lymphocytes. We hypothesize that such imDC are important in controlling the proinflammatory environment in vivo in patients with MS.